Cue Biopharma, Inc. (CUE) Soars 8.3%: Is Further Upside Left in the Stock? Posted byZacks Equity Research January 27, 2022 Leave a comment on Cue Biopharma, Inc. (CUE) Soars 8.3%: Is Further Upside Left in the Stock? Cue Biopharma, Inc. (CUE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in…